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substitutions previously reported to mediate ceftaroline resist-
ance (Table 1). Two isolates (ASARM167 and A38) belonging to
ST22 (epidemic MRSA-15) had an E239K substitution in PBP2a.
ASARM167 was isolated from a patient with bacteraemia at
Cambridge University Hospitals NHS Foundation Trust (CUH) in
2008 and A38 was isolated from a canine wound infection in
2006 treated in Wiltshire, south-west England.8 Phylogenetic ana-
lysis of these two isolates based on core genome SNPs placed
them in different clades separated by .120 SNPs (data not
shown), indicating that the E239K mutation arose independently
in these two isolates. The third isolate (ASARM130) had the N146K
substitution in PBP2a, belonged to ST241 (CC8) and was isolated
from a patient with bacteraemia at CUH in 2007. This isolate was
also noted to have an N204K substitution, which has not been
reported previously in isolates with the N146K substitution.2,3
The effect of these PBP2a substitutions on the ceftaroline resist-
ance phenotype was evaluated for these three isolates using the
disc diffusion assay based on EUCAST guidelines10 and the Etest
(bioMe´rieux, Lyon, France) according to the manufacturer’s instruc-
tions. Two isolates were susceptible and one was resistant to cef-
taroline by disc diffusion, but all three isolates were susceptible by
Etest (Table 1). Although isolates with the N146K substitution
have been reported previously to have an MIC of 0.5 mg/L (suscep-
tible), all previously reported isolates with E239K had an MIC of
≥2 mg/L (resistant).2,4 The lack of association between a resistant
phenotype and the N146K substitution indicates that secondary
chromosomal mutations are likely to be involved, as reported previ-
ously.4,7 The three study isolates were cultured before the clinical
introduction of ceftaroline into clinical practice in the USA in 2010
and Europe in 2012, demonstrating that these are natural variants
of PBP2a that occur (albeit at low prevalence) even without pressure
from ceftaroline use. All previously reported isolates with PBP2a sub-
stitutions mediating ceftaroline resistance belonged to CC5 and
CC8, which has led to the suggestion that these two lineages
might be more prone to such mutations. Our findings suggest
that they probably occur in multiple MRSA lineages including the
pandemic CC22 lineage, which is important in many parts of the
world including Australia and the Middle East and is the dominant
MRSA lineage in the UK and much of Europe.
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Sir,
Tetracycline can still be used for treatment of infections caused
by Gram-negative organisms that lack resistance genes. In
Acinetobacter baumannii tetracycline resistance is often caused
by tetA(A) and tetA(B), which encode efflux pumps,1,2 and occa-
sionally by tet(M), which encodes a ribosomal protection protein.1
In addition, a novel determinant, tet39 (tetA39-tetR39), was
found in tetracycline-resistant Acinetobacter strains recovered
from freshwater fish farms in Denmark3 and Thailand4 and from
a clinical Acinetobacter calcoaceticus/baumannii complex isolate
recovered from human urine in 1986.3 The tetA39 gene encodes
an efflux pump that was reported to confer resistance to tetracyc-
line but not minocycline.3
In strains belonging to global clone 1 (GC1), the tetA(A) gene is
part of the AbaR resistance island5 while in GC2 isolates the
tetA(B) gene is found in an AbGRI1 resistance island.6 However,
there is little information about the tetracycline resistance deter-
minants and their context in strains that do not belong to the two
major global clones. Here, we have examined the cause of tetra-
cycline resistance in RCH52, a clinical multiply antibiotic-resistant
A. baumannii strain recovered prior to 2010 in a Queensland
hospital.
RCH52 was found to be resistant to ampicillin, ceftazidime,
ticarcillin/clavulanic acid, imipenem, meropenem, streptomycin,
spectinomycin, sulphonamides, trimethoprim, kanamycin, genta-
micin and tetracycline. The genome of RCH52 was sequenced
using the Illumina Hiseq platform and assembled as described
previously,7 generating 60 contigs. RCH52 was ST729 (Institut
Pasteur scheme), a novel single locus variant of ST3 (rpoB4 in
ST729 differs from rpoB3 in ST3 by a single base pair) and
RCH52 therefore belongs to the European clone III. To the best
of our knowledge this is the first report of the European clone III
in Australia. ResFinder 2.1 (https://cge.cbs.dtu.dk//services/
ResFinder/) was used to identify resistance genes, and RCH52 con-
tains aphA1b, aacC2, aadA1, floR, cmlA1, arr-2, sul1, sul2, dfrA14,
oxa10, blaTEM, oxa23 (encoding a variant of OXA-23 differing by
four amino acids) and the tet39 determinant, accounting for the
resistances observed. The comM gene is uninterrupted and
ISAba1 was not found upstream of the ampC gene.
The tet39 determinant was found on an 11 kb contig that
was shown to be circular using PCR followed by sequencing. The
plasmid carrying tet39, named pRCH52-1 (GenBank accession
number KT346360; Figure 1), is 11146 bp. Plasmid DNA was
(a)
(b)
Figure 1. Linearized map of pRCH52-1 compared with other plasmids. (a) Comparison of the original tet39 region found in pLUH5605 with the
corresponding region found in pRCH52-1 and pAB1H8. (b) pRCH52-1 compared with the cryptic plasmids pAb-G7-1 and pD72-1 seen in GC1 and GC2
strains, respectively. Arrows indicate the extent and direction of genes and ORFs. The tetA gene and tetR genes of tet39 are shown in red and rep genes
are coloured blue. The tonB gene encodes a TonB-dependent transporter homologue. The green box indicates ISAba125 and the arrow inside represents
the transposase gene. The extents of regions with significant DNA identities are shown in grey and red numbers represent DNA identities. A scale bar is
also shown. The picture is drawn to scale from the following GenBank entries: pRCH52-1, GenBank accession number KT346360; pAb-G7-1, GenBank
accession number KJ586856; pD72-1, GenBank accession number KM051986; pLUH5605, GenBank accession number AY743590; and pAB1H8, GenBank
accession number ANNC01000048. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.
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isolated and electroporated into A. baumannii ATCC 17978, which
is tetracycline susceptible. Transformants were selected on L-agar
supplemented with 20 mg/L tetracycline (transformation
frequency¼4.5×107 transformants/mg of DNA). None of the
transformants grew on L-agar containing other antibiotics that
RCH52 was resistant to, indicating that only the tetracycline resist-
ance had transferred into the recipient cells. Primers tet39-F
(5′-GCAGCTAATGCCCATACCAT-3′) and tet39-R (5′-GCCTTTTGC
GTTGTTACCAT-3′) were designed to amplify a 219 bp internal frag-
ment of the tetA39 gene. This PCR generated the expected prod-
uct for all of the transformants tested. Although it was reported
that tet39 does not confer resistance to minocycline,3 transfor-
mants tested here exhibited reduced susceptibility to minocycline,
with inhibition zone diameters of 18 mm compared with 26 mm
for ATCC 17978.
The original study showed that tet39 was located on
plasmids but only a 3727 bp fragment of one plasmid (named
here pLUH5605) was sequenced (GenBank accession number
AY743590). This sequence, the only complete tet39 sequence
found in the GenBank non-redundant database, includes
tetA39, tetR39 and two ORFs (Figure 1a), one of which encodes
a replication initiation protein.3 Only 2360 bp of the pLUH5605
sequence was present in pRCH52-1 (Figure 1a). To explore the
distribution of the tet39 determinant in Acinetobacter strains,
the whole genome sequence database of NCBI was explored
using the sequences of pRCH52-1 and pLUH5605. Twenty-one
Acinetobacter strains belonging to different species were found
to contain tet39 (Table S1, available as Supplementary data at
JAC Online). However, the tet39 region appears to be in different
contexts in all but one A. baumannii strain, AB1H8 (GenBank
accession number ANNC01000048). AB1H8 appears to include a
plasmid that contains a Rep that is 97% identical in terms of
amino acids to the pLUH5605 RepA (Figure 1a). Hence, discrete
boundaries surrounding tet39 were not found.
pRCH52-1 encodes a replication initiation protein Rep that
belongs to the Rep_3 superfamily (pfam01051) and differs
from the Rep found in pLUH5605 by 43%. The pRCH52-1 Rep is
identical to the Rep protein found in a strain belonging to the
A. calcoaceticus/baumannii complex (NCBI Reference Sequence
number WP_000845850). Thereafter, the closest Rep is RepAci7
(GenBank accession number GU978996), with 96% amino acid
identity.
pRCH52-1 also encodes a TonB-dependent transporter
homologue. These outer membrane proteins bind and transport
siderophores, vitamin B12, nickel complexes and carbohy-
drates.8 This gene is also present in several cryptic plasmids of
A. baumannii,6,7,9,10 including pAb-G7-1 and pD72-1 from GC1
and GC2 strains, respectively. However, the amino acid sequence
of Rep encoded by pRCH52-1 differs from those in pAb-G7-1
(GenBank accession number KJ586856) and pD72-1 (GenBank
accession number KM051986) by 24% and 21%, indicating that
the tonB gene, which is a potential virulence determinant, is widely
distributed.
The tet39 determinant is widespread in Acinetobacter spe-
cies. It has also been found in other species of Gram-negative
and Gram-positive bacteria recovered from a polluted Nigerian
river.11 Its location on plasmids in clinical isolates would facili-
tate the spread of tetracycline resistance amongst
Acinetobacter strains, leading to further restriction of treatment
options.
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